QQ客服 官方微博 反馈留言

	Targeting Wnt/β-Catenin Signaling for Cancer Immunotherapy
	Wang Bojun[1]; Tian Tian[2]; Kalland Karl-Henning[3]; Ke Xisong[4]; Qu Yi[5]
刊名	Trends in pharmacological sciences
	2018
卷号	39页码:648-658
关键词	Wnt cancer combination therapy immunotherapy resistance β-catenin
ISSN号	1873-3735
URL标识	查看原文
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/2181013
专题	上海大学
作者单位	1.[1]Innovation Center of Chemical Biology, Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, Shanghai, P.R. China 2.These authors contributed equally to the manuscript. 3.[2]Innovation Center of Chemical Biology, Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, Shanghai, P.R. China 4.These authors contributed equally to the manuscript. 5.[3]Department of Clinical Science, University of Bergen, Bergen, Norway. 6.[4]Innovation Center of Chemical Biology, Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, Shanghai, P.R. China. Electronic address: xisongke@shutcm.edu.cn. 7.[5]Innovation Center of Chemical Biology, Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, Shanghai, P.R. China. Electronic address: yiqu@shutcm.edu.cn.
推荐引用方式 GB/T 7714	Wang Bojun[1],Tian Tian[2],Kalland Karl-Henning[3],et al. Targeting Wnt/β-Catenin Signaling for Cancer Immunotherapy[J]. Trends in pharmacological sciences,2018,39:648-658.
APA	Wang Bojun[1],Tian Tian[2],Kalland Karl-Henning[3],Ke Xisong[4],&Qu Yi[5].(2018).Targeting Wnt/β-Catenin Signaling for Cancer Immunotherapy.Trends in pharmacological sciences,39,648-658.
MLA	Wang Bojun[1],et al."Targeting Wnt/β-Catenin Signaling for Cancer Immunotherapy".Trends in pharmacological sciences 39(2018):648-658.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。